Metastatic Colon Cancer Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colon cancer metastatic / Stage IV Colon Cancer / Colon cancer stage IV / Malignant neoplasm of colon stage IV / Colon cancer Duke's D / Malignant neoplasm of colon stage IV, unspecified

DBCOND0033231 (Metastatic Colon Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT00826540Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerTreatment